サマリー

エグゼクティブサマリー

2020年のMRIシステムの世界市場規模は71億3,000万米ドルでした。慢性疾患の増加、MRIシステム分野の技術的進歩、老年人口の増加がMRIシステムの使用を世界的に促進し、それゆえ予測期間2021-2026年の間に市場の成長の道を開くことになります。

2020年の世界市場では、1.5T～3Tが圧倒的なシェアを獲得しています。世界的には、これらの強度のいずれかのスキャナーでMRI診断が行われている。3T以上の磁場MRIシステムは、他のスキャナーよりも画質が向上しているため、ますます普及が進んでいます。

MRIシステムの世界市場は、北米地域が最大のシェアを占め、欧州がそれに続くと推定されます。しかし、APAC地域の新興市場は、今後数年間で最も速い成長率を目撃することになるでしょう。

この市場の成長を促す主な要因としては、心血管疾患、乳がん、神経疾患、筋骨格系疾患などの慢性疾患の有病率の上昇、早期診断のメリットに関する認識、低磁場MRIシステムから高磁場MRIシステムへの置き換えにつながる技術の進歩、世界の高齢化率の上昇、などが挙げられます。磁気共鳴イメージング市場の成長を推進するその他の要因は、先進国および発展途上国市場における国民皆保険の採用の増加、製品発売の増加、高強度MRI装置の採用、新興潜在市場における医療インフラの増加、AIインスピレーションMRI処置の登場である。



報告書の範囲

- 本レポートでは、2016年～2020年の過去期間と2021年～2026年の予測期間におけるMRI装置市場の分析を紹介しています。

- このレポートでは、MRIシステム市場を金額（百万米ドル）別に分析しています。

- このレポートでは、MRIシステム市場をアーキテクチャ別（クローズドMRIシステム、オープンMRIシステム）に分析しています。

- MRI装置市場を磁場強度別（1.5T未満、1.5T〜3T、3T以上）に分析したレポートです。

- このレポートでは、MRIシステム市場をアプリケーション別（神経学、筋骨格、循環器学、その他）に分析しています。

- MRIシステムの世界市場は、国別（米国、カナダ、ドイツ、フランス、イタリア、英国、中国、日本、インド、オーストラリア）に分析されています。

- 本レポートの主要な洞察は、SWOT分析の枠組みを通じて提示されています。また、市場の魅力は、地域別、建築物別、分野別、アプリケーション別に提示されています。

- また、業界の主な機会、動向、ドライバー、課題についても分析されています。

- 本レポートでは、競合他社の動向、戦略、M&A、新製品開発などを追跡しています。分析対象企業は、Siemens Healthineers、General Electric、Phillips、Canon Medical Systems Corp.、日立製作所、Fonar Corporation、Esaote SpA、Anke high-tech co. ltd、Time medical systems、MR solutionsです。

主な対象読者

- MRI装置メーカー・ベンダー

- メディカルイメージング業界

- コンサルティング・アドバイザリーファーム

- 政府機関および研究機関

- 医療機器規制当局

ページTOPに戻る

目次

1. Report Scope and Methodology

1.1 Scope of the Report

1.2 Research Methodology

1.3 Executive Summary

2. Strategic Recommendations

3. MRI Systems Market: Product Overview

4. Global MRI Systems Market: An Analysis

4.1 Market Size, By Value, 2016-2026

4.2 Impact of COVID-19 on MRI Systems Market

4.3 Global MRI Systems Market: Growth & Forecast

5. Global MRI Systems Market Segmentation, By Architecture (Value)

5.1 Competitive Scenario of Global MRI Systems Market: By Architecture

5.2 Global MRI Systems Market: Segment Analysis

5.3 By Closed MRI Systems– Market Size and Forecast (2016-2026)

5.4 By Open MRI Systems– Market Size and Forecast (2016-2026)

6. Global MRI Systems Market Segmentation, By Field Strength (Value)

6.1 Competitive Scenario of Global MRI Systems Market: By Field Strength (2020 & 2026)

6.2 Global MRI Systems Market: Segment Analysis

6.3 By Less than 1.5T– Market Size and Forecast (2016-2026)

6.4 By 1.5T - 3T– Market Size and Forecast (2016-2026)

6.5 By More than 3T– Market Size and Forecast (2016-2026)

7. Global MRI Systems Market Segmentation, By Application (Value)

7.1 Competitive Scenario of Global MRI Systems Market: By Application (2020 & 2026)

7.2 Global MRI Systems Market: Segment Analysis

7.3 By Neurology– Market Size and Forecast (2016-2026)

7.4 By Musculoskeletal– Market Size and Forecast (2016-2026)

7.5 By Cardiology– Market Size and Forecast (2016-2026)

7.6 By Others– Market Size and Forecast (2016-2026)

8. Global MRI Systems Market: Regional Analysis

8.1 Competitive Scenario of Global MRI Systems Market: By Region (2020 & 2026)

9. North America MRI Systems Market: An Analysis (2016-2026)

9.1 North America MRI Systems Market: Size and Forecast (2016-2026), By Value

9.2 North America MRI Systems Market – Prominent Companies

9.3 Market Segmentation By Architecture (Closed MRI Systems and Open MRI Systems)

9.4 Market Segmentation By Field Strength (Less than 1.5T, 1.5T - 3T and More than 3T)

9.5 Market Segmentation By Application (Neurology, Musculoskeletal, Cardiology and Others)

9.6 North America MRI Systems Market: Country Analysis

9.7 Market Opportunity Chart of North America MRI Systems Market - By Country, By Value (Year-2026)

9.8 Competitive Scenario of North America- By Country

9.9 United States MRI Systems Market: Size and Forecast (2016-2026), By Value

9.10 United States MRI Systems Market Segmentation By Architecture, By Field Strength, By Application (2016-2026)

9.11 Canada MRI Systems Market: Size and Forecast (2016-2026), By Value

9.12 Canada MRI Systems Market Segmentation By Architecture, By Field Strength, By Application (2016-2026)

10. Europe MRI Systems Market: An Analysis (2016-2026)

10.1 Europe MRI Systems Market: Size and Forecast (2016-2026), By Value

10.2 Europe MRI Systems Market: Prominent Companies

10.3 Market Segmentation By Architecture (Closed MRI Systems and Open MRI Systems)

10.4 Market Segmentation By Field Strength (Less than 1.5T, 1.5T - 3T and More than 3T)

10.5 Market Segmentation By Application (Neurology, Musculoskeletal, Cardiology and Others)

10.6 Europe MRI Systems Market: Country Analysis

10.7 Market Opportunity Chart of Europe MRI Systems Market - By Country, By Value (Year-2026)

10.8 Competitive Scenario of Europe MRI Systems Market– By Country (2020 & 2026)

10.9 Germany MRI Systems Market: Size and Forecast (2016-2026)

10.10 Germany MRI Systems Market Segmentation By Architecture, By Field Strength, By Application (2016-2026)

10.11 France MRI Systems Market: Size and Forecast (2016-2026)

10.12 France MRI Systems Market Segmentation By Architecture, By Field Strength, By Application (2016-2026)

10.13 Italy MRI Systems Market: Size and Forecast (2016-2026)

10.14 Italy MRI Systems Market Segmentation By Architecture, By Field Strength, By Application (2016-2026)

10.15 United Kingdom MRI Systems Market: Size and Forecast (2016-2026)

10.16 United Kingdom MRI Systems Market Segmentation By Architecture, By Field Strength, By Application (2016-2026)

11. Asia Pacific MRI Systems Market: An Analysis (2016-2026)

11.1 Asia Pacific MRI Systems Market by value: Size and Forecast (2016-2026)

11.2 Asia Pacific MRI Systems Market: Prominent Companies

11.3 Market Segmentation By Architecture (Closed MRI Systems and Open MRI Systems)

11.4 Market Segmentation By Field Strength (Less than 1.5T, 1.5T - 3T, More than 3T)

11.5 Market Segmentation By Application (Neurology, Musculoskeletal, Cardiology and Others)

11.6 Asia Pacific MRI Systems Market: Country Analysis

11.7 Market Opportunity Chart of Asia Pacific MRI Systems Market - By Country, By Value (Year-2026)

11.8 Competitive Scenario of Asia Pacific MRI Systems Market– By Country (2020 & 2026)

11.9 China MRI Systems Market: Size and Forecast (2016-2026)

11.10 China MRI Systems Market Segmentation By Architecture, By Field Strength, By Application (2016-2026)

11.11 Japan MRI Systems Market: Size and Forecast (2016-2026)

11.12 Japan MRI Systems Market Segmentation By Architecture, By Field Strength, By Application (2016-2026)

11.13 India MRI Systems Market: Size and Forecast (2016-2026)

11.14 India MRI Systems Market Segmentation By Architecture, By Field Strength, By Application (2016-2026)

11.15 Australia MRI Systems Market: Size and Forecast (2016-2026)

11.16 Australia MRI Systems Market Segmentation By Architecture, By Field Strength, By Application (2016-2026)

12. Global MRI Systems Market Dynamics

12.1 Global MRI Systems Market Drivers

12.2 Global MRI Systems Market Restraints

12.3 Global MRI Systems Market Trends

13. Market Attractiveness and Strategic Analysis

13.1 Market Attractiveness Chart of Global MRI Systems Market - By Architecture (Year 2026)

13.2 Market Attractiveness Chart of Global MRI Systems Market - By Field Strength (Year 2026)

13.3 Market Attractiveness Chart of Global MRI Systems Market - By Application (Year 2026)

13.4 Market Attractiveness Chart of Global MRI Systems Market – By Region (Year 2026)

14. Competitive Landscape

14.1 Market Share of Leading Global Companies

14.2 SWOT Analysis– Global MRI Systems Market

15. Global MRI Systems Market: Major Technological Innovations, Merger & Acquisitions, Recent Developments

16. Company Profiles (Business Description, Financial Analysis, Business Strategy)

16.1 Siemens Healthineers

16.2 General Electric

16.3 Philips

16.4 Canon Medical Systems

16.5 Hitachi Ltd.

16.6 Fonar Corporation

16.7 Anke High-tech

16.8 Esaote SpA

16.9 Time Medical Systems

16.10 MR Solutions



Figure 1: Global MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 2: Number of magnetic resonance imaging (MRI) units in selected countries as of 2019, (per million population)

Figure 3: Radiologists Per 100,000 people in Selected Countries, 2018

Figure 4: Global burden of disease by cause measured in Disability-Adjusted Life Years, in millions, in 2018

Figure 5: Global burden of musculoskeletal conditions region wise in millions, year 2020

Figure 6: Global Estimated number of Cancer incidences and prevalent cases (all ages, in millions), Year 2020

Figure 7: Global Cancer related number of deaths (all ages, in millions), Year 2020

Figure 8: Current Healthcare Expenditure (% Share of GDP), By Selected Country, 2014-2018 (In %)

Figure 9: Global Aged Population (Above 65), 2016-20 (% of total Population)

Figure 10: Global Aged Population (Above 65), By Country, 2020 (% of total Population)

Figure 11: Global MRI Systems Market- By Architecture Market Share, 2020 & 2026

Figure 12: Global MRI Systems Market- By Closed MRI Systems, By Value (USD Million), 2016-2026

Figure 13: Global MRI Systems Market- By Open MRI Systems, By Value (USD Million), 2016-2026

Figure 14: Global MRI Systems Market- By Field Strength Market Share, 2020 & 2026

Figure 15: Global MRI Systems Market- By Less than 1.5T, By Value (USD Million), 2016-2026

Figure 16: Global MRI Systems Market- By 1.5T – 3T, By Value (USD Million), 2016-2026

Figure 17: Global MRI Systems Market- By More than 3T, By Value (USD Million), 2016-2026

Figure 18: Global MRI Systems Market - By Application Market Share, 2020 & 2026

Figure 19: Global MRI Systems Market- By Neurology, By Value (USD Million), 2016-2026

Figure 20: Global MRI Systems Market- By Musculoskeletal, By Value (USD Million), 2016-2026

Figure 21: Global MRI Systems Market- By Cardiology, By Value (USD Million), 2016-2026

Figure 22: Global MRI Systems Market- By Others, By Value (USD Million), 2016-2026

Figure 23: Global MRI Systems Market- By Region Market Share, 2020 & 2026

Figure 24: North America MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 25: North America Current health expenditure per capita (current USD), 2014-18

Figure 26: North America Population ages 65 and above (% of total Population), 2016-20

Figure 27: Burden of Neurological Conditions in the region in 2019, (in % terms per 100,000 population)

Figure 28: North America estimated number of Cancer incidences and prevalent cases (in millions), Year 2020

Figure 29: North America Cancer related number of deaths (all ages, in thousand's), Year 2020

Figure 30: North America Current health expenditure per capita (current USD), 2014-18

Figure 31: North America Population ages 65 and above (% of total Population), 2016-20

Figure 32: North America MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 33: North America MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 34: North America MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 35: Market Opportunity Chart of North America MRI Systems Market- By Country, By Value (Year-2026)

Figure 36: North America MRI Systems Market- By Country Market Share, 2020 & 2026

Figure 37: United States MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 38: United States Current health expenditure per capita (current USD), 2015-2019

Figure 39: United States Population aged 65 and above (% of total Population), 2016-20

Figure 40: Number of deaths (per 100,000 people) from Neurological conditions in the U.S., 2016-19

Figure 41: Cancer Prevalence in United States, 2020

Figure 42: United States MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 43: United States MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 44: United States MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 45: Canada MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 46: Number of deaths (per 100,000 people) from Neurological conditions in Canada, 2016-19

Figure 47: Estimated number of Cancer Prevalent cases in Canada, 2020

Figure 48: Key areas of Expenditure in Canada Medical Technology

Figure 49: Canada Current health expenditure per capita (current USD), 2014-19

Figure 50: Canada Population aged 65 and above (% of total Population), 2016-20

Figure 51: Canada MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 52: Canada MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 53: Canada MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 54: Europe MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 55: Europe Current health expenditure per capita (current USD), 2015-18

Figure 56: Total expenditure on health per capita in European countries (in USD PPP), 2019

Figure 57: Europe Population ages 65 and above (% of total Population), 2016-20

Figure 58: Population ages 65 and above (% of total Population) in European Countries, 2020

Figure 59: Europe estimated number of Cancer prevalence (all ages, in thousands), Year 2020

Figure 60: Europe Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)

Figure 61: Europe Prevalence of Neurological Disorders, 2015-2019 (In Millions)

Figure 62: Europe MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 63: Europe MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 64: Europe MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 65: Market Opportunity Chart of Europe MRI Systems Market- By Country, By Value (Year-2026)

Figure 66: Europe MRI Systems Market- By Country Market Share, 2020 & 2026

Figure 67: Germany MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 68: Germany Healthcare Industry Scenario (2016-2019)

Figure 69: Germany, Population ages 65 and above (% total), 2016-2020

Figure 70: Germany, Estimated percentage of prevalent Cancer cases, 2020

Figure 71: Germany Prevalence of Neurological Disorders, 2015-2019 (In Millions)

Figure 72: Germany Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)

Figure 73: Germany MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 74: Germany MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 75: Germany MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 76: France MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 77: France Current health expenditure per capita (current USD ), 2015-19

Figure 78: France, Population ages 65 and above (% of total Population), 2016-20

Figure 79: France Prevalence of Neurological Disorders, 2015-2019 (In Millions)

Figure 80: France Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)

Figure 81: France, Estimated percentage of prevalent Cancer cases, 2020

Figure 82: France MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 83: France MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 84: France MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 85: Italy MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 86: Italy Current health expenditure per capita (current USD), 2015-19

Figure 87: Italy Population ages 65 and above (% of total Population), 2016-20

Figure 88: Italy Prevalence of Neurological Disorders, 2015-2019 (In Millions)

Figure 89: Italy Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)

Figure 90: Italy, Estimated percentage of prevalent Cancer cases, 2020

Figure 91: Italy MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 92: Italy MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 93: Italy MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 94: United Kingdom MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 95: United Kingdom Current health expenditure per capita, PPP USD, 2015-19

Figure 96: United Kingdom Population ages 65 and above (% of total Population), 2016-20

Figure 97: United Kingdom Prevalence of Neurological Disorders, 2015-2019 (In Millions)

Figure 98: United Kingdom Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)

Figure 99: United Kingdom, Estimated percentage of prevalent Cancer cases, 2020

Figure 100: United Kingdom MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 101: United Kingdom MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 102: United Kingdom MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 103: Asia Pacific MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 104: Asia Pacific, Current health expenditure per capita (current USD), 2015-18

Figure 105: Asia Pacific, Current health expenditure per capita, by countries (current USD), 2019

Figure 106: Asia Pacific, Population ages 65 and above (% of total Population), 2016-20

Figure 107: Asia Pacific Population ages 65 and above, by Countries (% of total Population), 2020

Figure 108: Number of MRI units in APAC countries as of 2019, (per million population)

Figure 109: Asia Pacific Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)

Figure 110: Different Cancers prevalence in Asia Pacific (all ages, in thousands), Year 2020

Figure 111: Asia Pacific MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 112: Asia Pacific MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 113: Asia Pacific MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 114: Market Opportunity Chart of APAC MRI Systems Market- By Country, By Value (Year-2026)

Figure 115: APAC MRI Systems Market- By Country Market Share, 2020 & 2026

Figure 116: China MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 117: China Current health expenditure per capita (current USD), 2014-18

Figure 118: China Population ages 65 and above (% of total Population), 2016-20

Figure 119: China Prevalence of Neurological Disorders, 2015-2019 (In Millions)

Figure 120: China Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)

Figure 121: Estimated number of Cancer prevalent cases in China (all ages, in thousands), Year 2020

Figure 122: China MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 123: China MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 124: China MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 125: Japan MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 126: Japan Healthcare Expenditure Outlook (%)

Figure 127: Japan Population ages 65 and above (% of total Population), 2016-20

Figure 128: Japan Prevalence of Neurological Disorders, 2015-2019 (In Millions)

Figure 129: Japan Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)

Figure 130: Estimated number of Cancer prevalent cases in Japan (all ages, in thousands), Year 2020

Figure 131: Japan MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 132: Japan MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 133: Japan MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 134: India MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 135: Estimated value of public health spending in India (from 2017-20, in billions USD)

Figure 136: India population ages 65 and above (% of total Population), 2016-20

Figure 137: India Prevalence of Neurological Disorders, 2015-2019 (In Millions)

Figure 138: India Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)

Figure 139: Estimated number of Cancer prevalent cases in India (all ages, in thousands), Year 2020

Figure 140: India MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 141: India MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 142: India MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 143: Australia MRI Systems Market Size, By Value, 2016-2026 (USD Million)

Figure 144: Australia Current health expenditure per capita (current USD), 2014-19

Figure 145: Australia Population ages 65 and above (% of total Population), 2016-20

Figure 146: Australia Prevalence of Neurological Disorders, 2015-2019 (In Millions)

Figure 147: Australia Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)

Figure 148: Estimated number of Cancer prevalent cases in Australia (all ages, in thousands), Year 2020

Figure 149: Australia MRI Systems Market- By Architecture, By Value (USD Million), 2016-2026

Figure 150: Australia MRI Systems Market- By Field Strength, By Value (USD Million), 2016-2026

Figure 151: Australia MRI Systems Market- By Application, By Value (USD Million), 2016-2026

Figure 152: Market Attractiveness Chart of Global MRI Systems Market- By Architecture (Year-2026)

Figure 153: Market Attractiveness Chart of Global MRI Systems Market- By Field Strength (Year-2026)

Figure 154: Market Attractiveness Chart of Global MRI Systems Market – By Application, By Value (Year 2026)

Figure 155: Market Attractiveness Chart of Global MRI Systems Market- By Region (Year-2026)

Figure 156: Global MRI Systems company market share (%), 2020

Figure 157: Siemens Healthineers Annual Sales Revenue, 2017-2021 (USD Million)

Figure 158: Siemens Healthineers Net Income, 2017-2021 (USD Million)

Figure 159: Siemens Healthineers Sales Revenue, By Business Segment (%), FY2021

Figure 160: Siemens Healthineers Sales Revenue, By Geographical Segment (%), FY2021

Figure 161: General Electric Annual Sales Revenue, 2016-2020 (USD Million)

Figure 162: General Electric Net Income, 2016-2020 (USD Million)

Figure 163: General Electric Sales Revenue, By Business Segment (%), FY2020

Figure 164: General Electric Sales Revenue, By Geographical Segment (%), FY2020

Figure 165: Philips Annual Sales Revenue, 2016-2020 (USD Million)

Figure 166: Philips Net Income, 2016-2020 (USD Million)

Figure 167: Philips Sales Revenue, By Business Segment (%), FY2020

Figure 168: Philips Sales Revenue, By Geographical Segment (%), FY2020

Figure 169: Canon Medical Systems Annual Sales Revenue, 2016-2020 (USD Million)

Figure 160: Canon Medical Systems Net Income, 2016-2020 (USD Million)

Figure 171: Canon Medical Systems Corporation Sales Revenue, By Business Segment (%), FY2020

Figure 172: Canon Medical Systems Corporation Sales Revenue, By Geographical Segment (%), FY2020

Figure 173: Hitachi Ltd. Annual Sales Revenue, 2016-2020 (USD Million)

Figure 174: Hitachi Ltd. Net Income, 2016-2020 (USD Million)

Figure 175: Hitachi Ltd. Sales Revenue, By Business Segment (%), FY2020

Figure 176: Hitachi Ltd. Sales Revenue, By Geographical Segment (%), FY2020

Figure 177: Fonar Corporation Annual Sales Revenue, 2017-2021 (USD Million)

Figure 178: Fonar Corporation Gross Profit, 2017-2021 (USD Million)

Figure 179: Fonar Corporation Sales Revenue, By Business Segment (%), FY2021

Figure 180: Fonar Corporation Sales Revenue, By Geographical Segment (%), FY2021